Caco-2 cell permeability assays to measure drug absorption.
about
Fitting Transporter Activities to Cellular Drug Concentrations and Fluxes: Why the Bumblebee Can FlyEfficacy, Pharmacokinetics, and Metabolism of Tetrahydroquinoline Inhibitors of Plasmodium falciparum Protein FarnesyltransferaseReview on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic MicroorganismThe Brassica-derived phytochemical indolo[3,2-b]carbazole protects against oxidative DNA damage by aryl hydrocarbon receptor activation.Towards a rational design of solid drug nanoparticles with optimised pharmacological properties.Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers.Intestinal absorption and bioavailability of traditional Chinese medicines: a review of recent experimental progress and implication for quality control.The kinetic, mechanistic and cytomorphological effects of palytoxin in human intestinal cells (Caco-2) explain its lower-than-parenteral oral toxicity.Back to the future: can physical models of passive membrane permeability help reduce drug candidate attrition and move us beyond QSPR?Sucralose, a synthetic organochlorine sweetener: overview of biological issuesChallenges for blood-brain barrier (BBB) screening.In-vitro Cellular Uptake and Transport Study of 9-Nitrocamptothecin PLGA Nanoparticles Across Caco-2 Cell Monolayer ModelCompetitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model.Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles.Discovery, synthesis, and biological evaluation of novel SMN protein modulators.How do antimalarial drugs reach their intracellular targets?Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative ColitisValidated HPLC Method for Concurrent Determination of Antipyrine, Carbamazepine, Furosemide and Phenytoin and its Application in Assessment of Drug Permeability through Caco-2 Cell Monolayers.Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets DeterminationIntracellular accumulation of Praziquantel in T lymphoblastoid cell lines, CEM (parental) and CEMVBL(P-gp-overexpressing).Assessment of In Vivo Clinical Product Performance of a Weak Basic Drug by Integration of In Vitro Dissolution Tests and Physiologically Based Absorption Modeling.Evaluation of the intestinal permeability of rosemary (Rosmarinus officinalis L.) extract polyphenols and terpenoids in Caco-2 cell monolayers.Induction of the Estrogenic Marker Calbindn-D₉k by OctamethylcyclotetrasiloxaneDrug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers.Strategies to assess the drug interaction potential in translational medicine.The University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research for Women's Health: from plant to clinical use.Modeling kinetics of subcellular disposition of chemicals.Development of a screening assay for ligands to the estrogen receptor based on magnetic microparticles and LC-MS.Simulation-Based Approaches for Determining Membrane Permeability of Small CompoundsApplication of Gut Cell Models for Toxicological and Bioactivity Studies of Functional and Novel Foods.Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics.In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.Toxoplasma gondii Infection Promotes Epithelial Barrier Dysfunction of Caco-2 Cells.Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells.Drug metabolism and disposition diversity of Ranunculales phytometabolites: a systems perspective.Nitric oxide synthase and structure-based inhibitor design.Potential role for human P-glycoprotein in the transport of lacosamide.Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP.Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.
P2860
Q26780025-6D94A317-C3CC-4A53-8458-0CE9E1D21D78Q27646528-1B77C861-6C2D-432E-A01A-743CB0CD141EQ28068567-130CFBD5-960A-4536-A401-EDFE6597942FQ30315579-9A16C799-C215-44CE-8B57-30EC49D72CD4Q30372133-9A86E746-1ED8-4917-A986-F513A29A6905Q34028741-3D67FFA6-04DC-40EF-822C-08904B167665Q34033700-06FDEF21-F4E7-400F-B35E-421D07647963Q34340279-7D9E251F-E61D-4091-AD09-E67155D06563Q34351404-6F2F6F41-9C4C-44AB-91BB-A8415BF367CCQ34445710-A8F86C4E-FB36-494A-9547-6807FA491DD8Q34657381-95DD3D7C-2A03-4B5F-BD48-47FC5BEDAEA5Q34707666-F97116CC-39AA-4454-A041-655F5AC65116Q35046472-A2EC4E6E-D370-408C-AA37-282FC280BD05Q35073199-D94FA95C-D047-4A1A-A645-E429D967DFBEQ35137881-0F02489E-09DD-408F-9BD3-E1A84FAFA349Q35216315-BB022578-12DA-42F3-9712-6BC37BA1278DQ35569450-E23F97FA-78BC-4BFA-9C59-A0D19B337CBAQ35668327-06AFC629-17E0-431B-BA2A-AB889EFD9C54Q35801298-25BB133A-9BF8-4DDA-B584-E1E0F7301A15Q35996034-F2819A35-6681-41BA-AF40-DDA71D45C1C5Q36103626-D569B488-0AAF-4169-B857-137CD6DB0580Q36232481-50266969-C7B7-4336-AF50-6AAB2DE1D107Q36289570-D7132A59-9CBA-4D8B-A6EA-4B687DDA0352Q36324193-6DD21538-0AB1-4449-8BEE-CEC23F12791FQ36362462-7DCF9FBE-9AC4-4F64-90D3-B8DD09D0A29BQ36609743-76C90003-74AE-45B3-8863-3FC9194BD910Q36820989-57567B12-BF47-40E7-8A5C-8227FB731758Q37194304-A05F7AE8-97AA-43E5-AEEB-161B842BC586Q37328982-F912F521-B34F-4100-ABC1-FAF7123D28FAQ37614213-9428E60E-EEEE-4610-9C7E-C13B8A6C103BQ37635876-70C8B5C8-ADAB-49D9-B7DF-1590FCF92BC5Q37969214-A107E0B2-301F-4852-9A5C-744F25B63997Q38131859-6B47AC76-FFE7-46C7-AF72-9780AFC23A44Q38760352-5EFE10D4-9095-407D-8A9D-937D541E8624Q38810143-C835FCF3-BF41-4624-9F93-A69262D0B27BQ38854048-4F20967A-A8AC-492C-9DD2-101168539269Q39021613-F93B33E1-2E3B-47E3-A0F3-6FD579F08887Q39172259-37F9736F-CE63-4FA6-807B-80592D79AA22Q39233839-7306E062-51C7-425C-B59E-C465EA0DE26BQ39252003-35C6EF2A-7EB1-40E0-936C-323BF9BDA97F
P2860
Caco-2 cell permeability assays to measure drug absorption.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Caco-2 cell permeability assays to measure drug absorption.
@ast
Caco-2 cell permeability assays to measure drug absorption.
@en
type
label
Caco-2 cell permeability assays to measure drug absorption.
@ast
Caco-2 cell permeability assays to measure drug absorption.
@en
prefLabel
Caco-2 cell permeability assays to measure drug absorption.
@ast
Caco-2 cell permeability assays to measure drug absorption.
@en
P2860
P356
P1476
Caco-2 cell permeability assays to measure drug absorption
@en
P2093
Yongmei Li
P2860
P304
P356
10.1517/17425255.1.2.175
P407
P577
2005-08-01T00:00:00Z